Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)
CNY 40.96
(2.24%)
CNY 40.96
(2.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 360.25 Million | 235.95 Million | 4.07 Million | - | - | - |
| Cost of Revenue | 24.05 Million | 16.96 Million | 295.8 Thousand | 7.13 Million | 5.98 Million | 5.51 Million |
| Gross Profit | 336.2 Million | 218.98 Million | 3.78 Million | -7.13 Million | -5.98 Million | -5.51 Million |
| Operating Expenses | 175.02 Million | 96.57 Million | 24.08 Million | 27.63 Million | 320.89 Million | 17.64 Million |
| Selling, General and Administrative Expenses | 152.54 Million | 92.81 Million | 7.69 Million | 4.2 Million | 2.82 Million | 2.12 Million |
| Research and Development Expenses | 22.45 Million | 7.92 Million | 13.23 Million | 17.89 Million | 178.66 Million | 13.5 Million |
| Other Expenses | -36.75 Thousand | -4.16 Million | 3.15 Million | 5.53 Million | 139.39 Million | 2 Million |
| Cost and Expenses | 164.8 Million | 113.54 Million | 24.38 Million | 27.63 Million | 320.89 Million | 17.64 Million |
| Operating Income | 195.45 Million | 151.58 Million | -20.3 Million | -21.84 Million | -315.19 Million | -12.58 Million |
| Interest Expense | 321.97 Thousand | 3113.57 | 588.86 Thousand | 12.24 Thousand | 6700.00 | - |
| Income Tax Expense | 25.34 Million | 6.7 Million | -5.28 Million | -95.94 Thousand | -6.01 Million | 5.05 Million |
| Earnings before Tax | 186.9 Million | 149.56 Million | -9.28 Million | -21.84 Million | -315.22 Million | -12.58 Million |
| Net Income | 161.55 Million | 142.85 Million | -3.99 Million | -21.75 Million | -309.21 Million | -12.58 Million |
| Earnings Per Share Basic | 0.79 | 0.90 | -0.03 | -0.14 | -1.95 | -0.12 |
| Earnings Per Share Diluted | 0.79 | 0.90 | -0.03 | -0.14 | -1.95 | -0.12 |
| Weighted Average Shares Outstanding | 205.75 Million | 158.27 Million | 158.27 Million | 158.27 Million | 158.27 Million | 104.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 205.75 Million | 158.27 Million | 158.27 Million | 158.27 Million | 158.27 Million | 104.62 Million |
| Gross Margin | 0.93 | 0.93 | 0.93 | - | - | - |
| EBIT Margin | 0.54 | 0.67 | -1.26 | - | - | - |
| Profit Margin | 0.45 | 0.61 | -0.98 | - | - | - |
| EBITDA | 195.4 Million | 155.99 Million | -1.52 Million | -14.68 Million | -309.23 Million | -7.06 Million |
| Earnings Before Tax Margin | 0.54 | 0.64 | -4.98 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 47.45 Million | 52.96 Million | 68.37 Million | 358.64 Million | 80.68 Million | 78.77 Million |
| Cost of Revenue | 2.59 Million | 2.96 Million | 3.73 Million | 24.05 Million | 4.79 Million | 5.03 Million |
| Gross Profit | 44.85 Million | 49.99 Million | 64.64 Million | 334.59 Million | 75.88 Million | 73.73 Million |
| Operating Expenses | 51.85 Million | 48.43 Million | 38.99 Million | 175.02 Million | 46.6 Million | 48.59 Million |
| Selling, General and Administrative Expenses | 41.83 Million | 38.69 Million | 33.39 Million | - | 40.82 Million | 43.71 Million |
| Research and Development Expenses | 10.01 Million | 9.73 Million | 5.59 Million | - | 5.74 Million | 7.72 Million |
| Other Expenses | -4240.00 | -2.63 Million | -976.49 Thousand | -36.75 Thousand | -36.75 Thousand | -2.66 Million |
| Cost and Expenses | 54.44 Million | 51.4 Million | 42.72 Million | 199.07 Million | 51.39 Million | 53.63 Million |
| Operating Income | -6.99 Million | 1.56 Million | 25.65 Million | 159.56 Million | 29.28 Million | 32.88 Million |
| Interest Expense | 106.74 Thousand | 326.39 Thousand | 266.54 Thousand | 269.95 Thousand | 55.08 Thousand | 95.43 Thousand |
| Income Tax Expense | -998.45 Thousand | 136.57 Thousand | 4.29 Million | 25.34 Million | 4.69 Million | 3.7 Million |
| Earnings before Tax | -837.28 Thousand | 5.46 Million | 33.46 Million | 186.9 Million | 35.62 Million | 30.21 Million |
| Net Income | 161.17 Thousand | 5.33 Million | 29.17 Million | 161.55 Million | 30.93 Million | 26.51 Million |
| Earnings Per Share Basic | 0.00 | 0.03 | 0.18 | - | 0.20 | 0.17 |
| Earnings Per Share Diluted | 0.00 | 0.03 | 0.18 | - | 0.20 | 0.17 |
| Weighted Average Shares Outstanding | 204.69 Million | 205.75 Million | 158.27 Million | 158.27 Million | 158.27 Million | 158.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 204.69 Million | 205.75 Million | 158.27 Million | 158.27 Million | 158.27 Million | 158.27 Million |
| Gross Margin | 0.95 | 0.94 | 0.95 | 0.93 | 0.94 | 0.94 |
| EBIT Margin | -0.02 | 0.08 | 0.48 | - | 0.39 | 0.41 |
| Profit Margin | 0.00 | 0.10 | 0.43 | 0.45 | 0.38 | 0.34 |
| EBITDA | -730.53 Thousand | 4.4 Million | 32.84 Million | - | 31.61 Million | 32.05 Million |
| Earnings Before Tax Margin | -0.15 | 0.03 | 0.38 | 0.44 | 0.36 | 0.42 |
300786
600302
SYSCHEM
MMNGF
TRINITYLEA
NOBDF